1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow pegvisomant: new trials by email Literature Review of pegvisomant trials Research Report on pegvisomant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance Pegvisomant - Insulin Receptor Mutation, Partial Lipodystrophy | Phase 2 | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 25 | 2023-01-23 | 2026-08-18 |
| Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes pegvisomant - Diabetes, Metabolic Syndrome | Phase 2 | Completed | University of California, San Francisco | 6 | 2014-01-01 | 2017-04-24 |
Insulin Resistance (2) · Diabetes Mellitus (1) · Lipodystrophy, Partial, Acquired (1) · Metabolic Syndrome (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · University of California, San Francisco (1)
United States (2)
Ethan J Weiss, MD (1) · Kathleen Mulligan, PhD (1) · Morris Schambelan, MD (1) · Rebecca J Brown, M.D. (1)